Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 11.08%, which has investors questioning if this is right time ...

Q1 2025 Earnings Call Transcript May 13, 2025 Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Analysts have given Lexicon Pharmaceuticals a total of 5 ratings, with the consensus rating being Buy. The average one-year ...

On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 7 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks ...

Lexicon Pharmaceuticals (NASDAQ:LXRX) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-13. Here's a quick overview of what investors should know before the release. Analysts ...

Lexicon Pharmaceuticals (NASDAQ:LXRX) is scheduled to announce Q1 earnings results on Tuesday, May 13th, after market close. The consensus EPS Estimate is -$0.10 and the consensus Revenue Estimate is ...

Agenus (AGEN) came out with a quarterly loss of $1.03 per share versus the Zacks Consensus Estimate of a loss of $1.61. This compares to loss of $3.04 per share a year ago. These figures are ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 9, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be ...